Comment from Jonathan Szalajda

Summary: The commenter supports the broad acceptance of NIOSH-approved respirators in healthcare settings, arguing that NIOSH approval is a sufficient benchmark for worker protection and that dual regulation with the FDA creates unnecessary complexity. They urge the FDA to clarify the distinction between occupational respiratory protection claims and patient-facing medical claims to streamline regulatory pathways and improve supply-chain resilience.